1Bioregulation Department, Health and Science Institute, Federal University of Bahia, Salvador, Brazil
2Institute of Computing, Federal University of Bahia, Salvador, Brazil
3Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
4Endocrinology Department, Hospital de Braga, Braga, Portugal
5Laboratory of Pathology of the Institute of Pathology and Molecular Immunology, University of Porto, Porto, Portugal
6Department of Biomedical Genetics, University of Rochester, Rochester, New York, USA
7Faculty of Medicine, University of Porto, Porto, Portugal
8Postgraduate Program in Medicine and Health, Bahia Faculty of Medicine, Federal University of Bahia, Salvador, Brazil
© 2024 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ethics Statement
All procedures performed in the current study were approved by the Ethics Committee in Research of the Federal University of Bahia (CAAE 49095021.2.0000.5662) in accordance with the 1964 Helsinki declaration and its later amendments. Formal written informed consent was not required, waiver which was approved by the aforementioned ethics committee.
Availability of Data and Material
The datasets generated or analyzed during the study are not publicly available due to the proprietary nature of the data and privacy considerations inherent in cytological research, but are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
Author Contributions
Conceptualization: PRFR, HER. Data curation: PRFR, JMP, KSN, JV. Formal analysis: PRFR, JMP, HER. Investigation: PRFR, JMP, KSN, HER. Methodology: PRFR, JMP, JV, HER. Resources: PRFR, JMP, KSN, SL, JV, CE, HER. Software: JMP, JV. Supervision: HER. Visualization: PRFR, JMP, KSN, CE, HER. Writing—original draft: PRFR, JMP, KSN, CE, HER. Writing—review & editing: PRFR, JMP, KSN, SL, JV, FH, FELB, GJRM, ETK, CE, HER. Approval of final manuscript: all authors.
Conflicts of Interest
The authors declare that they have no potential conflicts of interest.
Funding Statement
No funding to declare.